DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,367 filers reported holding DANAHER CORPORATION in Q1 2019. The put-call ratio across all filers is 1.02 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,637,000 | -13.3% | 10,401 | +0.4% | 0.13% | +2.4% |
| Q1 2022 | $3,040,000 | -0.9% | 10,363 | +11.1% | 0.12% | -8.1% |
| Q4 2021 | $3,068,000 | -50.7% | 9,324 | -54.4% | 0.14% | -47.1% |
| Q3 2021 | $6,223,971 | +16.5% | 20,444 | +2.7% | 0.26% | +5.4% |
| Q2 2021 | $5,342,243 | +28.9% | 19,907 | +8.1% | 0.24% | +8.5% |
| Q1 2021 | $4,144,623 | +26.9% | 18,414 | +25.2% | 0.22% | +19.3% |
| Q4 2020 | $3,266,569 | +3.2% | 14,705 | 0.0% | 0.19% | -11.4% |
| Q3 2020 | $3,166,428 | +26.4% | 14,705 | +3.8% | 0.21% | +8.8% |
| Q2 2020 | $2,504,974 | +27.8% | 14,166 | 0.0% | 0.19% | -0.5% |
| Q1 2020 | $1,960,716 | -9.8% | 14,166 | 0.0% | 0.20% | +1.6% |
| Q4 2019 | $2,174,198 | +6.3% | 14,166 | 0.0% | 0.19% | -5.0% |
| Q3 2019 | $2,045,995 | +1.1% | 14,166 | 0.0% | 0.20% | 0.0% |
| Q2 2019 | $2,024,605 | +8.3% | 14,166 | 0.0% | 0.20% | -2.4% |
| Q1 2019 | $1,870,195 | +28.0% | 14,166 | 0.0% | 0.21% | +8.4% |
| Q4 2018 | $1,460,798 | -5.1% | 14,166 | 0.0% | 0.19% | +11.7% |
| Q3 2018 | $1,539,278 | +10.1% | 14,166 | 0.0% | 0.17% | +4.3% |
| Q2 2018 | $1,397,901 | -15.2% | 14,166 | -15.8% | 0.16% | -18.8% |
| Q1 2018 | $1,647,923 | +5.5% | 16,831 | 0.0% | 0.20% | +5.2% |
| Q4 2017 | $1,562,253 | +9.2% | 16,831 | +0.9% | 0.19% | +2.1% |
| Q3 2017 | $1,430,896 | – | 16,681 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |